combination glp-1 and sglt2 Receptor Agonist Therapy With Without Inhibitors in Patients With Type 2 Diabetes Effectiveness and safety of the

The new class of weight-loss medications are hailed as game-changing wonder drugs, but just how safe and effective are they

In patients with obesity (mean age 51.3 years, 65.6% women), semaglutide compared with non-GLP-1RA anti-obesity medications was associated with lower risk for incident CUD in patients with no prior history CUD (HR: 0.56, 95% CI: 0.420.75), and recurrent CUD diagnosis in patients with a prior history CUD (HR: 0.62, 95% CI: 0.460.84)

But how do GLP-1s actually work

Losing weight with GLP-1 drugs is only half the battle

Explore weight loss injections and schedule a weight loss appointment.

Muffins, donuts, cheesecakes, shakes & more that taste like dessert but support your weight loss goals